Katherine M Digianantonio

2PUBLICATIONS
29CO-AUTHORS
Molecular targetsChemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 31, 2024
Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models.

Sheryl M Gough, John J Flanagan, Jessica Teh

|Jan 06, 2017
A Non-natural Protein Rescues Cells Deleted for a Key Enzyme in Central Metabolism.

Katherine M Digianantonio, Maria Korolev, Michael H Hecht

Pageof 1